{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:33:29Z","timestamp":1787240009428,"version":"build-2736575974"},"reference-count":25,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Uncertainty remains about whether sickle cell trait (SCT) shortens life or predisposes to disease. Therefore, we examined whether SCT carriers had an increased risk of death or diseases linked to SCT. We studied 467\u2009779 general population individuals from the UK Biobank. All had undergone whole-exome sequencing and were observed prospectively for a median of 15 years. Individuals with SCT (n = 1253) were not at an increased risk of all-cause death (hazard ratio [HR], 1.04; 95% confidence interval [CI], 0.84-1.29) or cardiovascular death (1.34; 0.90-2.00) or for having myocardial infarction (0.72; 0.42-1.24), ischemic stroke (1.30; 0.88-1.94), pulmonary embolism (1.29; 0.84-1.99), or heart failure (0.79; 0.55-1.14) compared with noncarriers. However, SCT carriers had an increased risk of diabetes (HR, 1.30; 95% CI, 1.12-1.50), chronic kidney disease (HR, 1.46; 95% CI, 1.18-1.80), and hypertension (odds ratio, 1.24; 95% CI, 1.08-1.42). Surprisingly, the risk of cardiovascular death was increased in SCT carriers with diabetes when compared with noncarriers with diabetes (HR, 2.17; 95% CI, 1.14-4.12). To examine whether selection bias may explain why previous studies based on hospital-diagnosed SCT found an increased risk of cardiovascular disease, we repeated our analyses using hospital diagnoses of SCT from national registries, instead of defining SCT from genotyping. Individuals registered as SCT carriers in hospital registries had a markedly increased risk of all-cause death (HR, 2.24; 95% CI, 1.42-3.52) and ischemic stroke (2.92; 1.30-6.60), likely due to selection bias. In conclusion, SCT carriers were not at an increased risk of all-cause death or cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031872","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:00:52Z","timestamp":1779382852000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["No overall increased risk of death in individuals with sickle cell trait: a study of 467\u200a779 general population adults"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2793-1085","authenticated-orcid":false,"given":"Marie","family":"Warny","sequence":"first","affiliation":[{"name":"1Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-0738","authenticated-orcid":false,"given":"Andreas","family":"Glenth\u00f8j","sequence":"additional","affiliation":[{"name":"1Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"},{"name":"2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Afzal","sequence":"additional","affiliation":[{"name":"2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"3Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev and Gentofte, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodong","family":"Wei","sequence":"additional","affiliation":[{"name":"1Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-5114","authenticated-orcid":false,"given":"Jesper","family":"Petersen","sequence":"additional","affiliation":[{"name":"1Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-8187","authenticated-orcid":false,"given":"Jens","family":"Helby","sequence":"additional","affiliation":[{"name":"1Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"},{"name":"2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2026082011213651200_bib1","unstructured":"World Health Organization\n          . Sickle-cell anemia: report by the Secretariat. Accessed 1 March 2026. https:\/\/iris.who.int\/handle\/10665\/20890."},{"issue":"6","key":"2026082011213651200_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJM197002052820607","article-title":"Sudden death in sickle cell trait","volume":"282","author":"Jones","year":"1970","journal-title":"N Engl J Med"},{"issue":"13","key":"2026082011213651200_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM198709243171301","article-title":"Sickle-cell trait as a risk factor for sudden death in physical training","volume":"317","author":"Kark","year":"1987","journal-title":"N Engl J Med"},{"issue":"13","key":"2026082011213651200_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2024026899","article-title":"Sickle cell trait does not cause \u201csickle cell crisis\u201d leading to exertion-related death: a systematic review","volume":"145","author":"Weeks","year":"2025","journal-title":"Blood"},{"issue":"21","key":"2026082011213651200_bib5","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1182\/bloodadvances.2024014252","article-title":"Ancestry-independent risk of venous thromboembolism in individuals with sickle cell trait vs. Factor V Leiden","volume":"8","author":"Lin","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"2026082011213651200_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12787","article-title":"Prospective study of sickle cell trait and venous thromboembolism incidence","volume":"13","author":"Folsom","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"20","key":"2026082011213651200_bib7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"2026082011213651200_bib8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2026082011213651200_bib9","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1161\/STROKEAHA.114.006110","article-title":"Sickle cell trait and incident ischemic stroke in the atherosclerosis risk in communities study","volume":"45","author":"Caughey","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"2026082011213651200_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1056\/NEJMoa1516257","article-title":"Sickle cell trait, rhabdomyolysis, and mortality among U.S. Army Soldiers","volume":"375","author":"Nelson","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"2026082011213651200_bib11","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.amjmed.2022.03.024","article-title":"Sickle cell trait and risk for common diseases: evidence from the UK Biobank","volume":"135","author":"Hulsizer","year":"2022","journal-title":"Am J Med"},{"issue":"3","key":"2026082011213651200_bib12","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"7","key":"2026082011213651200_bib13","doi-asserted-by":"crossref","first-page":"e103020","DOI":"10.1371\/journal.pone.0103020","article-title":"IthaGenes: an interactive database for haemoglobin variations and epidemiology","volume":"9","author":"Kountouris","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"2026082011213651200_bib14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41588-025-02335-7","article-title":"Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effects","volume":"57","author":"Karczewski","year":"2025","journal-title":"Nat Genet"},{"issue":"7726","key":"2026082011213651200_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"2","key":"2026082011213651200_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000496058","article-title":"Cardiovascular outcomes in African Americans with sickle cell trait and chronic kidney disease","volume":"49","author":"Olaniran","year":"2019","journal-title":"Am J Nephrol"},{"issue":"2","key":"2026082011213651200_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4269\/ajtmh.20-1657","article-title":"Association of sickle cell trait with risk and mortality of COVID-19: results from the United Kingdom Biobank","volume":"105","author":"Resurreccion","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"2026082011213651200_bib18","first-page":"504","article-title":"Adverse clinical outcomes associated with sickle cell trait at high altitude","volume":"110","author":"Stafford","year":"2025","journal-title":"Haematologica"},{"issue":"1","key":"2026082011213651200_bib19","doi-asserted-by":"crossref","first-page":"e2030435","DOI":"10.1001\/jamanetworkopen.2020.30435","article-title":"Association of sickle cell trait with incidence of coronary heart disease among African American individuals","volume":"4","author":"Hyacinth","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5-6","key":"2026082011213651200_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/00333549251361764","article-title":"Cohort tracking of sickle cell trait\u2013positive births identified by newborn screening, California, 1991-2013: public health surveillance for sickle cell trait","volume":"140","author":"Paulukonis","year":"2025","journal-title":"Public Health Rep"},{"key":"2026082011213651200_bib21","first-page":"A187","article-title":"The accuracy of ICD-10 diagnostic codes for the identification of pneumothorax and pulmonary embolism: a retrospective study in two UK centres [abstract]","volume":"80","author":"Hamakarim","year":"2025","journal-title":"Thorax"},{"issue":"12","key":"2026082011213651200_bib22","doi-asserted-by":"crossref","first-page":"e2139748","DOI":"10.1001\/jamanetworkopen.2021.39748","article-title":"Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial-adjudicated direct follow-up data in the UK: secondary analysis of the ASCEND randomized clinical trial","volume":"4","author":"Harper","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2026082011213651200_bib23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2026082011213651200_bib24","doi-asserted-by":"crossref","first-page":"m131","DOI":"10.1136\/bmj.m131","article-title":"Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis","volume":"368","author":"Batty","year":"2020","journal-title":"The BMJ"},{"issue":"4","key":"2026082011213651200_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/2049463715569806","article-title":"Can large surveys conducted on highly selected populations provide valid information on the epidemiology of common health conditions? An analysis of UK Biobank data on musculoskeletal pain","volume":"9","author":"Macfarlane","year":"2015","journal-title":"Br J Pain"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/8\/1033\/2538244\/blood_bld-2025-031872-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/8\/1033\/2538244\/blood_bld-2025-031872-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:23:03Z","timestamp":1787239383000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/8\/1033\/568609\/No-overall-increased-risk-of-death-in-individuals"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031872","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,20]]},"published":{"date-parts":[[2026,8,20]]}}}